Free Trial

Verrica Pharmaceuticals (VRCA) SEC Filings & 10K Form

Verrica Pharmaceuticals logo
$0.60 +0.07 (+13.37%)
Closing price 07/1/2025 04:00 PM Eastern
Extended Trading
$0.61 +0.01 (+0.83%)
As of 06:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Verrica Pharmaceuticals SEC Filings

DateFilerForm TypeView
07/01/2025
7:02 AM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2025
3:45 PM
PRYGOCKI MARK A SR (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:45 PM
Eichenfield Lawrence (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:45 PM
Nguyen Diem (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:45 PM
Corcoran Gavin (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:57 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
2:20 PM
ARMISTICE CAPITAL, LLC (Filed by)
Verrica Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
05/13/2025
3:36 PM
Verrica Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2025
3:19 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
5:06 AM
Verrica Pharmaceuticals (Filer)
Form DEFR14A
04/22/2025
6:15 AM
Verrica Pharmaceuticals (Filer)
Form DEF 14A
04/22/2025
6:18 AM
Verrica Pharmaceuticals (Filer)
Form DEFA14A
04/22/2025
6:20 AM
Verrica Pharmaceuticals (Filer)
Form ARS
04/02/2025
3:31 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2025
3:31 PM
Corcoran Gavin (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/02/2025
3:32 PM
Corcoran Gavin (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
6:08 AM
Rosenberg Noah L. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/26/2025
6:10 AM
Rosenberg Noah L. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
11:15 PM
Verrica Pharmaceuticals (Filer)
Form EFFECT
03/18/2025
5:45 PM
Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:45 PM
Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
4:05 PM
Verrica Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/11/2025
3:23 PM
Verrica Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
4:01 PM
ARMISTICE CAPITAL, LLC (Filed by)
Verrica Pharmaceuticals (Subject)
Form SCHEDULE 13G
12/09/2024
5:22 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Verrica Pharmaceuticals (Subject)
Form SC 13G/A
12/09/2024
4:17 PM
Verrica Pharmaceuticals (Issuer)
Zawitz David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/09/2024
4:18 PM
Verrica Pharmaceuticals (Issuer)
Zawitz David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
3:55 PM
Verrica Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/21/2024
3:53 PM
Verrica Pharmaceuticals (Filer)
Form 424B5
11/20/2024
4:06 PM
Verrica Pharmaceuticals (Filer)
Form 424B5
11/20/2024
4:08 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
8:32 AM
Avoro Capital Advisors LLC (Filed by)
Verrica Pharmaceuticals (Subject)
Form SC 13G/A
11/06/2024
7:59 PM
Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/06/2024
8:02 PM
Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
8:03 PM
Kirby John J. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/06/2024
8:04 PM
Kirby John J. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
4:11 PM
Verrica Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/04/2024
3:17 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
3:15 PM
Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:16 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
3:37 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump wipes out trillions overnight… (Ad)

Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.

Whether you take some of that wealth for yourself depends on if you watch this controversial exposé
09/27/2024
3:15 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:15 PM
Manning Paul B (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
3:16 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
3:50 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2024
3:45 PM
Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
3:35 PM
Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
2:31 PM
Verrica Pharmaceuticals (Subject)
White Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
2:17 PM
Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
2:08 PM
Kohler Terry (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2024
6:56 AM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:07 AM
Verrica Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/23/2024
5:10 PM
Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
5:11 PM
Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
5:12 PM
Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
5:13 PM
Verrica Pharmaceuticals (Issuer)
White Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
2:51 PM
Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/22/2024
2:55 PM
Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/22/2024
2:47 PM
Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VRCA) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners